Table 3. Cost-utility analysis results.
Mean cost | QALY | ACER | Incremental cost | Incremental QALY | ICER | |
---|---|---|---|---|---|---|
No ERT | 15,075 | 0.42174 | 35,745 | 366,777 | 3.78864 | 96,809 |
ERT | 381,852 | 4.21038 | 90,693 |
ACER, average cost-effectiveness ratio; ERT, enzyme replacement therapy; ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life year.